Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries

JACC: Cardiovascular Interventions

Volumn 5, Issue 6, 2012, Pages 618-625

  Head, Stuart J ^a   Holmes, David R ^b   Mack, Michael J ^c   Serruys, Patrick W ^a   Mohr, Friedrich W ^d   Morice, Marie Claude ^e   Colombo, Antonio ^f   Kappetein, A Pieter ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAYO CLINIC   (United States)

^c BAYLOR HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^f SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

coronary artery bypass grafting (CABG); heart team; left main; multivessel coronary disease; percutaneous coronary intervention (PCI); randomized trial; real world; registry; SYNTAX

Indexed keywords

ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; DISEASE REGISTRY; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; STROKE; TREATMENT OUTCOME;

EID: 84862846015     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2012.02.013     Document Type: Article

References (19)

1. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009;373:1190-7.
2. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.
3. Morice MC, Serruys PW, Kappetein AP, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010;121:2645-53.
4. Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011;32:2125-34.
5. Boudriot E, Thiele H, Walther T, et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol 2011;57:538-45.
6. Kapur A, Hall RJ, Malik IS, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol 2010;55:432-40.
7. Head SJ, Bogers AJ, Serruys PW, Takkenberg JJ, Kappetein AP. A crucial factor in shared decision making: the team approach. Lancet 2011;377:1836.
8. Hannan EL. Drug-eluting stents vs. coronary-artery bypass grafting. N Engl J Med 2008;358:2643-4.
9. Ong AT, Serruys PW, Mohr FW, et al. The SYNergy Between Percutaneous Coronary Intervention With TAXus and Cardiac Surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 2006;151:1194-204. (Pubitemid 44172867)
10. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1:219-27.
11. Capodanno D, Stone GW, Morice MC, Bass TA, Tamburino C. Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data. J Am Coll Cardiol 2011;58:1426 -32.
12. Zheng S, Zheng Z, Hou J, Hu S. Comparison between drug-eluting stents and coronary artery bypass grafting for unprotected left main coronary artery disease: a meta-analysis of two randomized trials and thirteen observational studies. Cardiology 2011;118:22-32.
13. Park DW, Kim YH, Song HG, et al. Long-term comparison of drugeluting stents and coronary artery bypass grafting for multivessel coronary revascularization: 5-year outcomes from the Asan Medical Center-Multivessel Revascularization registry. J Am Coll Cardiol 2011;57:128-37.
14. Lee MS, Kapoor N, Jamal F, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drugeluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2006;47:864-70. (Pubitemid 43243113)
15. Rodés-Cabau J, Deblois J, Bertrand OF, et al. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation 2008;118:2374-81.
16. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network metaanalysis. Lancet 2007;370:937-48. (Pubitemid 47393576)
17. Mohr FW, Rastan AJ, Serruys PW, et al. Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. J Thorac Cardiovasc Surg 2011;141:130-40.
18. Capodanno D, Tamburino C. Integrating the synergy between percutaneous coronary intervention with Taxus and cardiac surgery (SYNTAX) score into practice: use, pitfalls, and new directions. Am Heart J 2011;161:462-70.
19. Birim O, van Gameren M, Bogers AJ, Serruys PW, Mohr FW, Kappetein AP. Complexity of coronary vasculature predicts outcome of surgery for left main disease. Ann Thorac Surg 2009;87:1097-104, discussion 1104-5.